Date Annoucement
14/11/2019 Final Share Issue to La Jolla Cove – Appendix 3B
28/12/2012 Change in Director’s Interest – M Rogers
14/12/2012 Change in Director’s Interest – M Halasz
04/12/2012 Change in Director’s Interest – M Halasz
04/12/2012 Change in Director’s Interest – M Rogers
23/11/2012 AGM presentation
23/11/2012 Result of Meeting
20/11/2012 Investor Presentation
09/11/2012 Change in Director’s Interest – M Rogers
07/11/2012 Change in Director’s Interest – D King
07/11/2012 Change in Director’s Interest – M Halasz
29/10/2012 Amended Top 20 Option Holders
29/10/2012 Dispatch of Options Entitlements Offer Holding Statements
24/10/2012 $545K Options Rights Issue Completed
24/10/2012 Annual Report to Shareholders
24/10/2012 Notice of Annual General Meeting and Proxy Form
22/10/2012 Appendix 4C – quarterly
02/10/2012 $748K R&D Tax Credit Received
02/10/2012 Change in Director’s Interest – M Halasz
30/09/2012 Appendix 4E and Preliminary Final Report
20/09/2012 Initial Director’s Interest Notice – M Rogers
19/09/2012 Appointment of Director
14/09/2012 Underwritten Non-Renounceable Pro-Rata Offer and Placement of Options
13/09/2012 évolis® Hair Growth Products Exceed Distribution Targets
04/09/2012 Exclusive Distributor Appointed for évolis®
28/08/2012 Initial Director’s Interest – G Kaufman
27/08/2012 Appointment and Resignation of Directors
21/08/2012 Appendix 3B
06/08/2012 Appointment of Joint Company Secretary
30/07/2012 Cellmid News
27/07/2012 Appendix 3B
26/07/2012 Midkine Ischemia Patent Allowed in US
23/07/2012 Appendix 4C
12/07/2012 Change of Director’s Interest Notice – M Halasz
25/06/2012 2nd Midkine Conference
07/06/2012 Appendix 3B
30/05/2012 évolis to be sold at Terry White
28/05/2012 Results of Meeting
25/05/2012 Change in substantial holding
11/05/2012 Ceasing to be a substantial holder
07/05/2012 Appendix 3B
07/05/2012 Treg Antibody Patent Allowed in USA
30/04/2012 Notice of Extraordinary General Meeting / Proxy Form
26/04/2012 Appendix 4C
24/04/2012 Cellmid Completes $1.5M Placement
19/04/2012 Commercial website launched for évolis™
18/04/2012 USA Antibody Patent for Adhesion Allowed
16/04/2012 Appendix 3B
04/04/2012 Appendix 3B
03/04/2012 Change of Director’s Interest Notice – R Beaumont
29/03/2012 Appendix 3B
29/03/2012 Media Launch of évolis™ Hair Products
16/03/2012 Appendix 3B
13/03/2012 Change of Director’s Interest Notice – M Halasz
06/03/2012 Appendix 3B
05/03/2012 Annual Report on Celera (Quest) License
28/02/2012 Appendix 3B
28/02/2012 Appendix 4D and Half Year Accounts
20/02/2012 Appendix 3B
20/02/2012 Notice of Change of Interest of Substantial Holder
15/02/2012 TGA Registration and Launch of Cellmid’s évolis™ Products
13/02/2012 La Jolla Funding Agreement Termination
30/01/2012 Appendix 3B
30/01/2012 Appendix 4C

 

 

Shop évolis®